CRCA vs. ILS
CRCA (ProShares Ultra CRCL) and ILS (Brookmont Catastrophic Bond ETF) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while ILS is a Nontraditional Bonds fund actively managed by Brookmont. Both are actively managed. At a correlation of -0.11, they often move in opposite directions. CRCA charges 0.95%/yr vs 1.58%/yr for ILS.
Performance
CRCA vs. ILS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -25.37% return, which is significantly lower than ILS's 1.81% return.
CRCA
- 1D
- -20.86%
- 1M
- -48.25%
- YTD
- -25.37%
- 6M
- -39.99%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ILS
- 1D
- 0.05%
- 1M
- 0.45%
- YTD
- 1.81%
- 6M
- 2.12%
- 1Y
- 7.67%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CRCA vs. ILS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -25.37% | -81.81% |
ILS Brookmont Catastrophic Bond ETF | 1.81% | 3.92% |
Correlation
The correlation between CRCA and ILS is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 8, 2025 | -0.11 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. ILS — Risk / Return Rank
CRCA
ILS
CRCA vs. ILS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Brookmont Catastrophic Bond ETF (ILS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| CRCA | ILS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 2.79 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.47 | 1.90 | -2.36 |
Drawdowns
CRCA vs. ILS - Drawdown Comparison
The maximum CRCA drawdown since its inception was -94.02%, which is greater than ILS's maximum drawdown of -1.56%. Use the drawdown chart below to compare losses from any high point for CRCA and ILS.
Loading charts...
Drawdown Indicators
| CRCA | ILS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.02% | -1.56% | -92.46% |
Max Drawdown (1Y)Largest decline over 1 year | — | -0.55% | — |
Current DrawdownCurrent decline from peak | -87.98% | 0.00% | -87.98% |
Average DrawdownAverage peak-to-trough decline | -69.26% | -0.25% | -69.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 0.17% | — |
Volatility
CRCA vs. ILS - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | ILS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 0.88% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 1.69% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 196.79% | 2.77% | +194.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 196.79% | 3.38% | +193.41% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 196.79% | 3.38% | +193.41% |
CRCA vs. ILS - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is lower than ILS's 1.58% expense ratio.
Dividends
CRCA vs. ILS - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 2.32%, less than ILS's 8.09% yield.
| Position | TTM | 2025 |
|---|---|---|
CRCA ProShares Ultra CRCL | 2.32% | 1.06% |
ILS Brookmont Catastrophic Bond ETF | 8.09% | 6.06% |
Frequently Asked Questions
CRCA and ILS have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CRCA is cheaper at 0.95% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CRCA is cheaper with a 0.95% expense ratio, compared with 1.58% for ILS.
ILS has the higher dividend yield at 8.09%, compared with 2.32% for CRCA.
CRCA is categorized as Leveraged Equities, while ILS is Nontraditional Bonds. They also come from different issuers: ProShares and Brookmont. Their fees differ too: 0.95% for CRCA and 1.58% for ILS.
Find the right allocation for CRCA and ILS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer